Esmolol to Treat the Hemodynamic Effects of Septic Shock

Clinical trial NCT02369900 · TERMINATED

Trial details

NCT number: NCT02369900
Sponsor: Beth Israel Deaconess Medical Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Septic Shock Hypotension Tachycardia

Start date: 2015-03-01
Primary completion: 2019-12-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.